FG
LMAT icon

Fairman Group’s LeMaitre Vascular LMAT Stock Holding History

Fairman Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13
Closed -$1.2K – 303
2024
Q4 		$1.2K Sell
13
-13
-50% -$1.25K ﹤0.01% 254
2024
Q3 		$2.42K Hold
26
– – ﹤0.01% 253
2024
Q2 		$2.14K Hold
26
– – ﹤0.01% 261
2024
Q1 		$1.73K Hold
26
– – ﹤0.01% 281
2023
Q4 		$1.48K Buy
+26
New +$1.36K ﹤0.01% 292

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fairman Group's LMAT Position: Q1 2025 in Review

Fairman Group sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 13 shares — an estimated $1.2K sold.

Fairman Group first reported a position in LMAT in Q4 2023 and held it in 5 quarters. The position peaked at $2.42K in Q3 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Fairman Group reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Fairman Group sold 13 LeMaitre Vascular shares in Q1 2025, an estimated $1.2K.
  • Fairman Group first reported a position in LeMaitre Vascular in Q4 2023 and held it in 5 quarters.
  • Fairman Group's LeMaitre Vascular position peaked at $2.42K in Q3 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.